These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 32619898)

  • 1. A divergent mode of activation of a nitrosyl iron complex with unusual antiangiogenic activity.
    Carvalho EM; Ridnour LA; Júnior FSG; Cabral PHB; do Nascimento NRF; Wink DA; Franco DW; de Medeiros MJC; de Lima Pontes D; Longhinotti E; de Freitas Paulo T; Bernardes-Génisson V; Chauvin R; Sousa EHS; Lopes LGF
    J Inorg Biochem; 2020 Sep; 210():111133. PubMed ID: 32619898
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thiol-Activated HNO Release from a Ruthenium Antiangiogenesis Complex and HIF-1α Inhibition for Cancer Therapy.
    Silva Sousa EH; Ridnour LA; Gouveia FS; Silva da Silva CD; Wink DA; de França Lopes LG; Sadler PJ
    ACS Chem Biol; 2016 Jul; 11(7):2057-65. PubMed ID: 27191177
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The macrocyclic effect and vasodilation response based on the photoinduced nitric oxide release from trans-[RuCl(tetraazamacrocycle)NO](2+).
    Oliveira Fde S; Ferreira KQ; Bonaventura D; Bendhack LM; Tedesco AC; Machado Sde P; Tfouni E; da Silva RS
    J Inorg Biochem; 2007 Feb; 101(2):313-20. PubMed ID: 17141326
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hemodynamic Effects of Glutathione-Liganded Binuclear Dinitrosyl Iron Complex: Evidence for Nitroxyl Generation and Modulation by Plasma Albumin.
    Liu T; Zhang M; Terry MH; Schroeder H; Wilson SM; Power GG; Li Q; Tipple TE; Borchardt D; Blood AB
    Mol Pharmacol; 2018 May; 93(5):427-437. PubMed ID: 29476040
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological characterization of 1-nitrosocyclohexyl acetate, a long-acting nitroxyl donor that shows vasorelaxant and antiaggregatory effects.
    Donzelli S; Fischer G; King BS; Niemann C; DuMond JF; Heeren J; Wieboldt H; Baldus S; Gerloff C; Eschenhagen T; Carrier L; Böger RH; Espey MG
    J Pharmacol Exp Ther; 2013 Feb; 344(2):339-47. PubMed ID: 23211362
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Photocontrollable nitric oxide (NO) and nitroxyl (HNO) donors and their release mechanisms.
    Nakagawa H
    Nitric Oxide; 2011 Aug; 25(2):195-200. PubMed ID: 21193058
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pentacyanoferrate(II) complex of pyridine-4- and pyrazine-2-hydroxamic acid as source of HNO: investigation of anti-tubercular and vasodilation activities.
    Carvalho EM; de Freitas Paulo T; Saquet AS; Abbadi BL; Macchi FS; Bizarro CV; de Morais Campos R; Ferreira TLA; do Nascimento NRF; Lopes LGF; Chauvin R; Sousa EHS; Bernardes-Génisson V
    J Biol Inorg Chem; 2020 Sep; 25(6):887-901. PubMed ID: 32728907
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biological activity of designed photolabile metal nitrosyls: light-dependent activation of soluble guanylate cyclase and vasorelaxant properties in rat aorta.
    Madhani M; Patra AK; Miller TW; Eroy-Reveles AA; Hobbs AJ; Fukuto JM; Mascharak PK
    J Med Chem; 2006 Dec; 49(25):7325-30. PubMed ID: 17149862
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nitroxyl inhibits breast tumor growth and angiogenesis.
    Norris AJ; Sartippour MR; Lu M; Park T; Rao JY; Jackson MI; Fukuto JM; Brooks MN
    Int J Cancer; 2008 Apr; 122(8):1905-10. PubMed ID: 18076071
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nitroxyl (HNO): the Cinderella of the nitric oxide story.
    Irvine JC; Ritchie RH; Favaloro JL; Andrews KL; Widdop RE; Kemp-Harper BK
    Trends Pharmacol Sci; 2008 Dec; 29(12):601-8. PubMed ID: 18835046
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Accumulation of HIF-1alpha under the influence of nitric oxide.
    Sandau KB; Fandrey J; Brüne B
    Blood; 2001 Feb; 97(4):1009-15. PubMed ID: 11159530
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heme versus non-heme iron-nitroxyl {FeN(H)O}⁸ complexes: electronic structure and biologically relevant reactivity.
    Speelman AL; Lehnert N
    Acc Chem Res; 2014 Apr; 47(4):1106-16. PubMed ID: 24555413
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nitric Oxide Resistance, Induced in the Myocardium by Diabetes, Is Circumvented by the Nitric Oxide Redox Sibling, Nitroxyl.
    Qin CX; Anthonisz J; Leo CH; Kahlberg N; Velagic A; Li M; Jap E; Woodman OL; Parry LJ; Horowitz JD; Kemp-Harper BK; Ritchie RH
    Antioxid Redox Signal; 2020 Jan; 32(1):60-77. PubMed ID: 31680536
    [No Abstract]   [Full Text] [Related]  

  • 14. Synthesis, properties, and reactivity of a series of non-heme {FeNO}(7/8) complexes: implications for Fe-nitroxyl coordination.
    Sanders BC; Patra AK; Harrop TC
    J Inorg Biochem; 2013 Jan; 118():115-27. PubMed ID: 23116685
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative detection of nitroxyl upon trapping with glutathione and labeling with a specific fluorogenic reagent.
    Johnson GM; Chozinski TJ; Salmon DJ; Moghaddam AD; Chen HC; Miranda KM
    Free Radic Biol Med; 2013 Oct; 63():476-84. PubMed ID: 23685286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reactivity of iron(II)-bound nitrosyl hydride (HNO, nitroxyl) in aqueous solution.
    Montenegro AC; Bari SE; Olabe JA
    J Inorg Biochem; 2013 Jan; 118():108-14. PubMed ID: 23153690
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Soluble guanylate cyclase is required for systemic vasodilation but not positive inotropy induced by nitroxyl in the mouse.
    Zhu G; Groneberg D; Sikka G; Hori D; Ranek MJ; Nakamura T; Takimoto E; Paolocci N; Berkowitz DE; Friebe A; Kass DA
    Hypertension; 2015 Feb; 65(2):385-92. PubMed ID: 25452469
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hydrolysis of acyloxy nitroso compounds yields nitroxyl (HNO).
    Sha X; Isbell TS; Patel RP; Day CS; King SB
    J Am Chem Soc; 2006 Aug; 128(30):9687-92. PubMed ID: 16866522
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design of an NO photoinduced releaser xerogel based on the controlled nitric oxide donor trans-[Ru(NO)Cl(cyclam)](PF6)2 (cyclam=1,4,8,11-tetraazacyclotetradecane).
    Ferreira KQ; Schneider JF; Nascente PA; Rodrigues-Filho UP; Tfouni E
    J Colloid Interface Sci; 2006 Aug; 300(2):543-52. PubMed ID: 16780861
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene expression profiles of NO- and HNO-donor treated breast cancer cells: insights into tumor response and resistance pathways.
    Cheng RY; Basudhar D; Ridnour LA; Heinecke JL; Kesarwala AH; Glynn S; Switzer CH; Ambs S; Miranda KM; Wink DA
    Nitric Oxide; 2014 Dec; 43():17-28. PubMed ID: 25153034
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.